Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization

ClinicalTrials.gov ID: NCT00288418

Public ClinicalTrials.gov record NCT00288418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters

Study identification

NCT ID
NCT00288418
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Angiotech Pharmaceuticals
Industry
Enrollment
960 participants

Conditions and interventions

Interventions

  • Central Venous Catheter Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Jun 30, 2007
Completion
Jun 30, 2007
Last update posted
Jan 22, 2013

2005 – 2007

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Cardio-Thoracic Surgeons, P.C. Birmingham Alabama 35235
Pulmonary Consultant Group Orange California 92868
Pulmonary Center Sharp Memorial Hospital San Diego California 92123
Kaiser Permanente Santa Teresa San Jose California 95119
Denver Health Medical Center Denver Colorado 80204
Christiana Care Research Institute Newark Delaware 19713
Florida Research Network, LLC Gainesville Florida 32605
Atlanta Institute for Medical Research Inc Decatur Georgia 30030
Kerry Thibodeaux, M.D. Opelousas Louisiana 70570
UMASS Medical School, Dept of Anesthesiology Worcester Massachusetts 01655
Newark Beth Israel Hospital Newark New Jersey 07112
Pulmonary and Critical Care Medicine Cincinnati Ohio 45267
St Vincent Mercy Medical Center, Bldg 1 Toledo Ohio 43608
Medical University of Ohio Toledo Ohio 43614
Universty of Oklahoma HSC Oklahoma City Oklahoma 73104
Drexel University College of Medicine Philadelphia Pennsylvania 19102
Rhode Island Hospital Providence Rhode Island 02903
Rapid City Regional Hospital Rapid City South Dakota 57701
University of Virginia, Department of Anesthesiology Charlottesville Virginia 22908
Winchester Medical Center Winchester Virginia 22601
Franciscan Health System Research Center Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00288418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00288418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →